|
|
|
|
|
Faro, Albert, M.D.
|
|
Associate Professor of Pediatrics
Dr. Faro is the physician co-leader of the 7 East Unit Based Joint Practice Team at St. Louis Children's Hospital.. He along with his co-leader and the staff of 7 East continue to work towards making 7 East a model in-patient unit for children with any pulmonary or allergy disorder. Dr. Faro’s research interests focus on improving our understanding of the mechanisms that lead to post-transplant bronchiolitis obliterans. He is one of several investigators involved in a multicenter study to determine if respiratory viruses do lead to the development of BO and by what immunologic mechanism does BO occur. Through the International Pediatric Lung Transplant Collaborative (IPLTC), which he co-founded, he has been involved in multiple projects including: the effects of prophylaxis against Cytomegalovirus post-transplant; the impact of fungal infections after lung transplant; the impact of lung transplant on the quality of life after lung transplantation in children with cystic fibrosis; and the establishment of an international pediatric lung transplant database. Dr. Faro is also passionate about finding new therapies that will improve the lives of children with cystic fibrosis. He is the co-director of the Cystic Fibrosis Therapeutics Development Network at Washington University and is involved in multicenter studies that will hopefully one day lead to therapies that will control, if not cure, this disease.
Dr. Faro is a former President of the IPLTC. He presently serves on the Executive Committee of the Pediatric Community of Practice of the American Society of Transplantation. He also serves on the American Academy of PediatricsSection on Pediatric Pulmonology Executive Committee; Section Nominations Committee. He has formerly served on the Education Committee of the American Society of Transplantation and the Executive Committee of the Pulmonary Section of the American Academy of Pediatrics.
|
Faro, Albert, M.D.
|
|
Associate Professor of Pediatrics
Dr. Faro is the physician co-leader of the 7 East Unit Based Joint Practice Team at St. Louis Children's Hospital.. He along with his co-leader and the staff of 7 East continue to work towards making 7 East a model in-patient unit for children with any pulmonary or allergy disorder. Dr. Faro’s research interests focus on improving our understanding of the mechanisms that lead to post-transplant bronchiolitis obliterans. He is one of several investigators involved in a multicenter study to determine if respiratory viruses do lead to the development of BO and by what immunologic mechanism does BO occur. Through the International Pediatric Lung Transplant Collaborative (IPLTC), which he co-founded, he has been involved in multiple projects including: the effects of prophylaxis against Cytomegalovirus post-transplant; the impact of fungal infections after lung transplant; the impact of lung transplant on the quality of life after lung transplantation in children with cystic fibrosis; and the establishment of an international pediatric lung transplant database. Dr. Faro is also passionate about finding new therapies that will improve the lives of children with cystic fibrosis. He is the co-director of the Cystic Fibrosis Therapeutics Development Network at Washington University and is involved in multicenter studies that will hopefully one day lead to therapies that will control, if not cure, this disease.
Dr. Faro is a former President of the IPLTC. He presently serves on the Executive Committee of the Pediatric Community of Practice of the American Society of Transplantation. He also serves on the American Academy of PediatricsSection on Pediatric Pulmonology Executive Committee; Section Nominations Committee. He has formerly served on the Education Committee of the American Society of Transplantation and the Executive Committee of the Pulmonary Section of the American Academy of Pediatrics.
|
|
|
|
|
|
|
-
1980-1984 BA, Columbia College Columbia University New York N.Y.
-
1984-1988 MD, University of Pittsburgh School of Medicine, Pittsburgh, P.A.
-
1980-1984 BA, Columbia College Columbia University New York N.Y.
-
1984-1988 MD, University of Pittsburgh School of Medicine, Pittsburgh, P.A.
|
|
|
|
|
|
- Intern in Pediatrics, Children's Hospital of Pittsburgh, 1988-1989
- Resident in Pediatrics, Children's Hospital of Pittsburgh, 1989-1991
- Fellow in Pulmonary Medicine, Children's Hospital of Pittsburgh, 1993-1996
- Intern in Pediatrics, Children's Hospital of Pittsburgh, 1988-1989
- Resident in Pediatrics, Children's Hospital of Pittsburgh, 1989-1991
- Fellow in Pulmonary Medicine, Children's Hospital of Pittsburgh, 1993-1996
|
|
|
|
|
|
- Missouri, 2005
- Pediatric Pulmonology, 1998, 2005
- Missouri, 2005
- Pediatric Pulmonology, 1998, 2005
|
|
|
|
|
|
- Best Doctors in America
- Marquis Who’s Who in Medicine and Healthcare
- Best Doctors in America
- Marquis Who’s Who in Medicine and Healthcare
|
|
|
|
|
|
1. Faro A, Mallory GB, Visner GA, Elidemir O, Mogayzel PJ, Danziger-Isakov L, Michaels M, Sweet SC, Michelson P, Phadke S, Conrad C, Waltz D. American Society of Transplantation Position Paper on Pediatric Lung Transplantation. Am J Transplant. 2007;7(2):285-92.
2. Elizur A , Sweet SC, Huddleston CB, Gandhi SK, Boslaugh SE, Kuklinski CA, Faro A. Pre-transplant mechanical ventilation increases short term morbidity and mortality in pediatric patients with cystic fibrosis. J Heart Lung Transplant 2007;26(2):127-31.
3. Faro A, Shepherd R, Huddleston C, Lowell J, Gandhi S, Nadler M, Sweet SC. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients. Transplantation 2007;83(11):1435-9.
4. Danziger-Isakov LA, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Michaels MG, Michelson P, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J Heart Lung Transplant 2008;27:655-661.
5. Faro A, Hamvas A. Lung transplantation for inherited disorders of surfactant metabolism. NeoReviews 2008;9:e468-476.
6. Elizur A, Faro A, Huddleston CB, Gandhi SK, White D, Kuklinski CA, Sweet SC. Lung Transplantation in Infants and Toddlers from 1990 to 2004 at St. Louis Children’s Hospital. American J Transplant 2009;9(4):719-26.
7. Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. Transplantation 2009;87(10):1541-8.
8. Liu M, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Visner G, Sweet S, Faro A, Michaels M, Danziger-Isakov LA. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis. 2009;11:304-312.
1. Faro A, Mallory GB, Visner GA, Elidemir O, Mogayzel PJ, Danziger-Isakov L, Michaels M, Sweet SC, Michelson P, Phadke S, Conrad C, Waltz D. American Society of Transplantation Position Paper on Pediatric Lung Transplantation. Am J Transplant. 2007;7(2):285-9
1. Faro A, Mallory GB, Visner GA, Elidemir O, Mogayzel PJ, Danziger-Isakov L, Michaels M, Sweet SC, Michelson P, Phadke S, Conrad C, Waltz D. American Society of Transplantation Position Paper on Pediatric Lung Transplantation. Am J Transplant. 2007;7(2):285-92.
2. Elizur A , Sweet SC, Huddleston CB, Gandhi SK, Boslaugh SE, Kuklinski CA, Faro A. Pre-transplant mechanical ventilation increases short term morbidity and mortality in pediatric patients with cystic fibrosis. J Heart Lung Transplant 2007;26(2):127-31.
3. Faro A, Shepherd R, Huddleston C, Lowell J, Gandhi S, Nadler M, Sweet SC. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients. Transplantation 2007;83(11):1435-9.
4. Danziger-Isakov LA, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Michaels MG, Michelson P, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J Heart Lung Transplant 2008;27:655-661.
5. Faro A, Hamvas A. Lung transplantation for inherited disorders of surfactant metabolism. NeoReviews 2008;9:e468-476.
6. Elizur A, Faro A, Huddleston CB, Gandhi SK, White D, Kuklinski CA, Sweet SC. Lung Transplantation in Infants and Toddlers from 1990 to 2004 at St. Louis Children’s Hospital. American J Transplant 2009;9(4):719-26.
7. Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. Transplantation 2009;87(10):1541-8.
8. Liu M, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Visner G, Sweet S, Faro A, Michaels M, Danziger-Isakov LA. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis. 2009;11:304-312.
1. Faro A, Mallory GB, Visner GA, Elidemir O, Mogayzel PJ, Danziger-Isakov L, Michaels M, Sweet SC, Michelson P, Phadke S, Conrad C, Waltz D. American Society of Transplantation Position Paper on Pediatric Lung Transplantation. Am J Transplant. 2007;7(2):285-9
|
|
|